CSIMarket
 


Pluristem Therapeutics Inc  (PSTI)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
   Industry Biotechnology & Drugs
   Sector  Healthcare
 

PSTI's Net Income Growth by Quarter and Year

Pluristem Therapeutics Inc's Net Income results by quarter and year




PSTI Net Income (in millions $) FY 2020 FY 2019 FY 2018 FY 2017
IV Quarter June - -7.76 -8.98 -7.02
III Quarter March - -10.08 -1.53 -7.86
II Quarter December -6.37 -8.68 -8.23 -6.61
I Quarter September -7.14 -8.79 -7.39 -6.32
FY   -13.51 -35.31 -26.13 -27.81



PSTI Net Income second quarter 2020 Y/Y Growth Comment
Pluristem Therapeutics Inc in the second quarter recorded net loss of $ -6.37 millions.

According to the results reported in the second quarter, Pluristem Therapeutics Inc achieved the best Net Income growth in Biotechnology & Drugs industry. While Pluristem Therapeutics Inc' s Net Income no change of % ranks overall at the positon no. in the second quarter.




PSTI Net Income ( Y/Y Growth %) 2020
2019 2018 2017
IV Quarter June - - - -
III Quarter March - - - -
II Quarter December - - - -
I Quarter September - - - -
FY   - - - -

Financial Statements
Pluristem Therapeutics Inc's second quarter 2020 Net Income $ -6.37 millions PSTI's Income Statement
Pluristem Therapeutics Inc's second quarter 2019 Net Income $ -8.68 millions Quarterly PSTI's Income Statement
New: More PSTI's historic Net Income Growth >>


PSTI Net Income (Quarter on Quarter Growth %)

2020
2019 2018 2017
IV Quarter June - - - -
III Quarter March - - - -
II Quarter December - - - -
I Quarter September - - - -
FY (Year on Year)   - - - -




Net Income second quarter 2020 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #

Net Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Net Income second quarter 2020 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #
Net Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Net Income by Quarter for the Fiscal Years 2017, 2018, 2019, 2020

Pluristem Therapeutics Inc's Q/Q Net Income Growth


Net Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


PSTI's II. Quarter Q/Q Net Income Comment
Even if Pluristem Therapeutics Inc in the II. Quarter 2020 revealed net loss of $ -6.37 millions, management point out, that those numbers show slight up side compare to the -7.14 millions in the first quarter.

Within Biotechnology & Drugs industry Pluristem Therapeutics Inc achieved highest sequential Net Income growth. While Pluristem Therapeutics Inc's Net Income growth quarter on quarter, overall rank is .


Net Income Q/Q Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #
Net Income Q/Q Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #
Net Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


PSTI's II. Quarter Q/Q Net Income Comment
Even if Pluristem Therapeutics Inc in the II. Quarter 2020 admitted net loss of $ -6.37 millions, it should be said, that this point to improvement in contrast to the -7.14 millions in the first quarter.

Within Biotechnology & Drugs industry Pluristem Therapeutics Inc achieved highest sequential Net Income growth. While Pluristem Therapeutics Inc's Net Income growth quarter on quarter, overall rank is .


Pluristem Therapeutics Inc's 12 Months Net Income Growth Year on Year


Net Income TTM Growth

12 Months Ending
(Dec 31 2019)
12 Months Ending
(Sep 30 2019)
12 Months Ending
(Jun 30 2019)
12 Months Ending
(Dec 31 2016)
12 Months Ending
(June 30. 2016)
Cumulative Net Income 12 Months Ending $ -31.35 $ -33.66 $ -35.31 $ -26.34 $ -23.25
Y / Y Net Income Growth (TTM) - - - - -
Year on Year Net Income Growth Overall Ranking # # # # #
Seqeuential Net Income Change (TTM) - - - - -
Seq. Net Income Growth (TTM) Overall Ranking # # # # #




Cumulative Net Income growth Comment
Pluristem Therapeutics Inc' has realized cumulative trailing twelve months net loss of $ -31 millions in the Dec 31 2019 period.

Pluristem Therapeutics Inc achieved highest trailing twelve month year on year Net Income growth. While overall Net Income growth ranking, remained unchanged compare to the previous quarter at no. .

Net Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Net Income TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #

Net Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Net Income growth Comment
Pluristem Therapeutics Inc' has realized cumulative trailing twelve months net loss of $ -31 millions in the Dec 31 2019 period.

Pluristem Therapeutics Inc achieved highest trailing twelve month year on year Net Income growth. While overall Net Income growth ranking, remained unchanged compare to the previous quarter at no. .

Net Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Income TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #

Net Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Net Income Growth
Biotechnology & Drugs Industry Net Income Growth Trends and Statistics
Healthcare Sector Net Income Growth Statistics
Net Income Growth Trends for overall market
PSTI's Net Income Growth Ratio versus Biotechnology & Drugs Industry, Healthcare Sector and total Market
Highest Ranking Net Income Growth
Lowest Ranking Net Income Growth
Net Income Growth for PSTI's Competitors
Net Income Growth for Pluristem Therapeutics Inc's Suppliers
Net Income Growth for PSTI's Customers

You may also want to know
PSTI's Annual Growth Rates PSTI's Profitability Ratios PSTI's Asset Turnover Ratio PSTI's Dividend Growth
PSTI's Roe PSTI's Valuation Ratios PSTI's Financial Strength Ratios PSTI's Dividend Payout Ratio
PSTI's Roa PSTI's Inventory Turnover Ratio PSTI's Growth Rates PSTI's Dividend Comparisons



Companies with similar Net Income no change for the quarter ending Dec 31 2019 within Healthcare SectorY/Y Change %Net Income for the quarter ending Dec 31 2019
Prestige Consumer Healthcare Inc. -0.62 %$ -0.618 millions
Zoetis Inc. -3.03 %$ -3.030 millions
Hill-rom Holdings, Inc. -5.69 %$ -5.687 millions
Quidel Corp -5.71 %$ -5.705 millions
Novartis Ag -6.95 %$ -6.953 millions
Catalent, Inc. -7.14 %$ -7.143 millions
Amgen Inc. -11.67 %$ -11.670 millions
Regeneron Pharmaceuticals, Inc. -11.85 %$ -11.846 millions
Petmed Express Inc -12.16 %$ -12.161 millions
Fonar Corp -13.47 %$ -13.466 millions
Phibro Animal Health Corp -19.35 %$ -19.352 millions
Cyanotech Corp -40.63 %$ -40.625 millions
Enanta Pharmaceuticals, Inc. -48.32 %$ -48.318 millions
Becton, Dickinson And Company -53.67 %$ -53.667 millions
Lannett Co Inc -58.87 %$ -58.874 millions
Vertex Pharmaceuticals Inc -61.76 %$ -61.758 millions
Meridian Bioscience Inc -65.12 %$ -65.125 millions
Stryker Corp -65.24 %$ -65.244 millions
Iqvia Holdings Inc. -73.68 %$ -73.684 millions
Shineco, Inc. -79.52 %$ -79.521 millions
Coherent, inc. -83.70 %$ -83.705 millions
Surmodics Inc -88.70 %$ -88.702 millions


             
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

BECN's Profile

Stock Price

BECN's Financials

Business Description

Fundamentals

Charts & Quotes

BECN's News

Suppliers

BECN's Competitors

Customers & Markets

Economic Indicators

BECN's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2020 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071